Trials / Completed
CompletedNCT01953081
A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Takeda · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This study is being conducted to evaluate the safety, tolerability and early efficacy of IV TD 8954 compared to metoclopramide in critically ill subjects, aged 18 to 85 years, who are admitted to the intensive care require mechanical ventilation, and are intolerant to enteral feeding.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TD-8954 | |
| DRUG | Metoclopramide |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-09-01
- Completion
- 2014-10-01
- First posted
- 2013-09-30
- Last updated
- 2020-02-18
- Results posted
- 2017-06-14
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT01953081. Inclusion in this directory is not an endorsement.